Studies on animal models of stress, anxiety, aggression, and sensorimotor gating have linked specific monoamine neurotransmitter abnormalities to the cognitive and behavioral disturbances associated with many affective neuropsychiatric disorders. Although ␣ 2 -adrenoceptors (␣ 2 -ARs) have been suggested to have a modulatory role in these disorders, the specific roles of each ␣ 2 -AR subtype (␣ 2A , ␣ 2B , and ␣ 2C ) are largely unknown. The restricted availability of relevant animal models and the lack of subtype-selective ␣ 2 -AR drugs have precluded detailed studies in this area. Therefore, transgenic mice were used to study the possible role of the ␣ 2C -AR subtype in two well established behavioral paradigms: prepulse inhibition (PPI) of the startle reflex and isolation-induced aggression. The ␣ 2C -AR-altered mice appear grossly normal, but subtle changes have been observed in their brain dopamine (DA) and serotonin (5-HT) metabolism. In this study, the mice with targeted inactivation of the gene encoding ␣ 2C -ARs (␣ 2C -KO) had enhanced startle responses, diminished PPI, and shortened attack latency in the isolation-aggression test, whereas tissue-specific overexpression of ␣ 2C -ARs (␣ 2C -OE) was associated with opposite effects. Correlation analyses suggested that both the magnitude of the startle response and its relative PPI (PPI%) were modulated by the mutations. In addition, the differences in PPI, observed between drug-naive ␣ 2C -OE mice and their wild-type controls, were abolished by treatment with a subtype nonselective ␣ 2 -agonist and antagonist. Thus, drugs acting via ␣ 2C -ARs might have therapeutic value in disorders associated with enhanced startle responses and sensorimotor gating deficits, such as schizophrenia, attention deficit disorder, post-traumatic stress disorder, and drug withdrawal.
The ␣ 2 -adrenoceptors (␣ 2 -ARs), which include three subtypes (␣ 2A , ␣ 2B , and ␣ 2C ) encoded by three genes, mediate many of the CNS effects of norepinephrine (N E) and regulate the release of NE, but also dopamine (DA), serotonin (5-HT), and other brain neurotransmitters (Ruffolo et al., 1993; MacDonald et al., 1997) . The expression of ␣ 2C -AR is distinct; it is restricted mainly to the CNS, being prominent in the striatum and hippocampus (Nicholas et al., 1996; MacDonald et al., 1997) . The ␣ 2 -ARs are known to have modulatory roles in various neuropsychiatric disorders, such as schizophrenia, post-traumatic stress disorder, depression, and various cognitive abnormalities (Hornykiewicz, 1982; Coull, 1994; Nutt, 1994; Ahmed and Takeshita, 1996; Arnsten et al., 1996) , but the significance of the ␣ 2 -ARs, especially the role of each ␣ 2 -AR subtype in these disorders, is poorly known. However, the most evident pharmacological effects attributed to CNS ␣ 2 -ARs, i.e., sedation, hypotension, hypothermia, and analgesia, appear to be mediated via ␣ 2A -ARs, whereas the role of ␣ 2C -ARs has remained obscure Hunter et al., 1997; Lakhlani et al., 1997; MacDonald et al., 1997; Stone et al., 1997) .
The startle reflex is a short-latency response of the skeletal musculature elicited by a sudden auditory stimulus (Davis et al., 1982; Yeomans and Frankland, 1995) . The startle reflex can be modulated by fear, stress, and other negative affective states (Davis, 1989; Howard and Ford, 1992) , and by different types of immediately preceding stimuli. Prepulse inhibition (PPI), i.e., the attenuation of the startle reflex response produced by a prepulse, is an important measure of sensorimotor gating (Geyer et al., 1990) . Like the startle reflex itself, PPI is also a cross-species phenomenon. Deficits in PPI are observed in schizophrenic patients (Braff et al., 1978) , and deficits in PPI can be induced in the rat with administrations of various schizophrenomimetics, such as D-amphetamine (D-Amph), 2,5-dimethoxy-4-iodoamphetamine (DOI), and phencyclidine (PCP), and after social isolation (Geyer et al., 1993; Bakshi et al., 1994; Swerdlow et al., 1994; Varty and Higgins, 1995) . Disrupted PPI can be normalized in rats by antipsychotics , and the PPI model is used in the development of new CNS drugs.
Because subtype-selective ␣ 2 -AR agonists or antagonists are not available, we have investigated the role of the ␣ 2C -AR in the startle reflex and its PPI in two genetically engineered mouse strains, one with targeted inactivation of the ␣ 2C -AR gene (␣ 2C -KO) and the other with tissue-specific overexpression of ␣ 2C -ARs (␣ 2C -OE) (Link et al., 1995; Sallinen et al., 1997) . Because these mice have subtle alterations in their brain DA and 5-HT metabolism that are specifically associated with the mutations, the startle and PPI responses were first determined from drug-naive mice with or without preceding isolation, and after D-Amph and PCP. In addition, the effects of subtype-nonselective ␣ 2 -AR drugs on startle and PPI were studied in ␣ 2C -OE mice and their wildtype controls. Finally, because social isolation and changes in brain 5-HT metabolism are also known to affect aggressive behavior, the mice were tested in the isolation-induced aggression paradigm.
MATERIALS AND METHODS

Animals.
A total of 449 8-to 17-week-old male mice were used; 64 mice from the BAL B/c strain (BOM, Bomholtgård, Denmark) were used as targets in isolation -aggression tests. All other mice were from the breeding colony maintained in the C entral Laboratory Animal Facility of the University of T urku, Finland. They represented two strains of genetically engineered mice and their wild-type controls, either littermates or those closely related to the mutants. The mutations were generated at Stanford University (Stanford, CA). One mutant strain had a targeted disruption of the ␣ 2C -AR gene (␣ 2C -KO), and the other had tissue-specific overexpression of ␣ 2C -ARs (␣ 2C -OE). The wild-type controls are designated as ␣ 2C -KO-wt and ␣ 2C -OE-wt, respectively.
The generation of both mutant strains has been described previously (Link et al., 1995; Sallinen et al., 1997) . Briefly, the ␣ 2C -AR gene was inactivated in 129/Sv embryonic stem cells (Nagy et al., 1993) , which were injected into C57BL /6J blastocysts, and the resulting chimeric mice were bred to F 1 (C57BL /6J ϫ DBA /2J) animals. These animals were backcrossed for several generations to C57BL /6J mice and then intercrossed, and the tested ␣ 2C -KO mice were offspring of closely related F 11-12 pairs, which were combinations of mice with wild-type, heterozygous, or homozygous genotypes for the ␣ 2C -AR mutation. All tested ␣ 2C -KO mice were homozygous for the mutation. The germline transmission of the mutation was monitored from mouse tail biopsies by Southern (DNA) analysis.
The ␣ 2C -OE mice were generated by pronuclear microinjection to one-cell fertilized eggs from the FV B/ N strain and are thus congenic. A tyrosinase minigene construct was coinjected for visual identification of the transgenic progeny on the basis of coat color (Overbeek et al., 1991) . The tested ␣ 2C -OE mice were heterozygous. According to brain in situ mRNA hybridization results and receptor autoradiograms, the overexpression of ␣ 2C -ARs is approximately threefold in ␣ 2C -OE mice in areas that normally express the receptor (Sallinen et al., 1997) . Correspondingly, ␣ 2C -AR binding is absent in the brains of ␣ 2C -KO mice (Link et al., 1995) .
The mice of both mutant strains are viable and fertile and appear grossly normal, and their diurnal patterns of locomotor activity do not differ from their wild-type littermates, although the background strains show different behavior. Compared with ␣ 2C -KO-wt mice, ␣ 2C -OE-wt mice have been shown to be more active, and the potency of ␣ 2 -AR agonists to induce locomotor inhibition is different between these strains of wild-type mice but not between respective mutant and wild-type mice. However, both mutant strains have subtle alterations in brain monoamine metabolism that are specifically associated with the mutations (Sallinen et al., 1997) .
The mice were housed in groups of 7-10 in standard polypropylene cages (38 ϫ 22 ϫ 15 cm) at 22 Ϯ 1°C and kept on a 12 hr light /dark cycle with light onset at 6 A.M. Some of the tested mice, however, were isolated for the experiments at the age of 6 -10 weeks; these mice were subsequently housed alone in smaller cages (22 ϫ 16 ϫ 13 cm). Their bedding was changed once a week, but otherwise they were not disturbed. E xperiments were conducted between 8:30 A.M. and 4 P.M.
The animal care was in accordance with the regulations of the International Council for Laboratory Animal Science, and the experiments had approval of the local committee for laboratory animal welfare.
Drugs. The following drugs were used: dexmedetomidine hydrochloride (3 or 10 g / kg) (Orion Corporation, Orion Pharma, T urku, Finland), atipamezole hydrochloride (100 g / kg) (Orion Pharma), D-amphetamine sulfate (0.25, 0.5, or 1.0 mg / kg) (Sigma, St. L ouis, MO), and phencyclidine hydrochloride (0.3, 1.0, or 3.0 mg / kg) (RBI, Natick, M A). All drugs were dissolved in distilled water, and the injection volume was 5 ml / kg (s.c.).
Startle apparatus and e xperimental design. The startle responses were measured with four identical ventilated and illuminated startle chambers [39 ϫ 38 ϫ 58 cm (length ϫ width ϫ height)] (SR-L AB system, San Diego Instruments, San Diego, CA). Each chamber consisted of a Plexiglas cylinder (3.9 cm in diameter) mounted on a removable frame on a base unit. Movement of the mouse within the cylinder was detected by a piezoelectric accelerometer attached below the frame. A loudspeaker (Radio Shack Supertweeter, San Diego, CA) mounted 25 cm above the cylinder, provided the background white noise and the acoustic stimuli.
Presentation of acoustic stimuli and the piezoelectric responses from the accelerometer were controlled and digitized by the SR-L AB software and interface system. Sensitivity of the chambers was adjusted at average readings of 250 using the standardization unit from San Diego Instruments. Sound levels within each chamber were measured repeatedly using the A weighting scale (Radio Shack Sound Level Meter, Fort Worth, TX) and were found to remain constant.
At the beginning of each startle session, the mice were placed in the startle chambers and exposed to 5 min of 72 dB background noise, which continued for the remainder of the session. The PUL SE intensity was 118 dB, and the PREPUL SE intensity was 3, 6, 9, or 15 dB above the 72 dB background level. The duration of both prepulses and pulses was 40 msec, and the prepulse -pulse interval was 100 msec. The allocation of different trial types and the intertrial intervals (7-30 sec) was pseudorandomized and kept unchanged within a study. The startle amplitudes from PUL SE AL ON E, PREPUL SE AL ON E, and PREPUL SE ϩ PUL SE stimuli were determined by averaging 100 readings of 1 msec each taken from the beginning of the PUL SE stimulus onset in PUL SE and PREPUL SE ϩ PUL SE trials, or from the beginning of the PRE-PUL SE in PREPUL SE AL ON E trials.
Three startle experiments were conducted with separate groups of mice. In the first experiment, 73 male ␣ 2C -OE and 68 male ␣ 2C -OE-wt mice were divided randomly into four groups and administered either the subtype nonselective ␣ 2 -agonist dexmedetomidine hydrochloride (Dex) (3 or 10 g / kg), the subtype nonselective ␣ 2 -antagonist atipamezole (Ati) (100 g / kg), or vehicle (distilled water) subcutaneously 20 min before the test session . In this first drug challenge, the startle session consisted of 30 trials with 10 PUL SE AL ON E, 10 PREPUL SE ϩ PUL SE, and 10 PREPUL SE AL ON E stimuli during a period of 11 min, and the prepulse intensity was set at 15 dB above background. These mice were not used in subsequent experiments.
In the second experiment, groups of ␣ 2C -KO (n ϭ 49), ␣ 2C -KO-wt (n ϭ 49), ␣ 2C -OE (n ϭ 42), and ␣ 2C -OE-wt (n ϭ 40) mice underwent three separate startle challenges as follows. In the first step, drug-naive mice were exposed to a 5 min startle session with 10 PUL SE and 6 PRE-PUL SE ϩ PUL SE trials, with prepulses 9 dB above background to determine the average baseline startle and PPI levels of each genotype group. Results from this experiment were then used to establish four matched treatment groups within each genotype group according to their responses to PUL SE AL ON E stimuli. In the second step on the next day, the same mice were given 0.25, 0.5, 1.0 mg / kg of D-Amph or vehicle 30 min before a startle session, which consisted of 30 PUL SE AL ON E, 10 PREPUL SE AL ON E (15 dB above background), and 40 PRE-PUL SE ϩ PUL SE trials (the prepulse level was 3, 6, 9, or 15 dB above background, 10 repetitions of each); these 80 stimuli were presented during a period of 18 min. In the third step, after at least 10 d, the same 18 min startle session was presented to the same mice starting 30 min after PC P injections (0.3, 1.0, or 3.0 mg / kg or vehicle). In this third challenge, the mice were rearranged to new matched treatment groups according to their initial startle responses: those mice that had received the same D-Amph doses in the previous experiment were put into different dose groups.
In the third startle experiment, the effect of isolation on startle responses and PPI was investigated in individually housed mice (see below) that had been studied once in the isolation -aggression test at least 1 week earlier. These mice were exposed to the same 5 min startle session that was used in the study with drug-naive group-housed mice in the first step of the second experiment.
Isolation-ag gression tests. A total of 64 drug-naive male mice (17 ␣ 2C -KO, 18 ␣ 2C -KO-wt, 14 ␣ 2C -OE, and 15 ␣ 2C -OE-wt) were analyzed for aggression after 6 weeks of isolation. On the basis of our preliminary tests, the aggressiveness of ␣ 2C -OE and ␣ 2C -OE-wt mice remaining in their home cages after isolation was extremely high, and the rating of attacks was difficult because of almost continuous fighting. To decrease the aggression level and to increase the sensitivity of the experiment, the tests were subsequently performed in a fresh cage identical to the home cages. Each isolated mouse was put into the test cage 1 min before the target (BAL B/c) mouse. The attack latency and number of attacks on the target mouse were measured during a 10 min session, starting from the introduction of the target mouse. An attack was given a score of one point when the isolated mouse bit the target mouse. If fighting continued for at least 10 sec, the same attack was scored as 2 points. The mice were analyzed for aggression only once. The observer was unaware of the expected results, but ␣ 2C -OE and ␣ 2C -OE-wt mice have different coat color and were tested first. ␣ 2C -KO and ␣ 2C -KO-wt mice could not be identified by visual inspection, and the observer was unaware of the randomized order of the mutant and wild-type mice.
Data anal ysis. The results are presented as mean Ϯ SEM. Statistical analysis was performed using STATISTICA 4.5 computer software (StatSoft, T ulsa, OK). ANOVA for repeated measurements showed that statistically significant habituation effects were occasionally present only in the second and third step of the second startle experiment (D-Amph and PC P challenges). These effects, however, were minor: reductions of the startle amplitude in the course of the session were between 10 and 20% in the vehicle group. In addition, alterations in responses during a session could have arisen from differences in drug action, in habituation, or in their interaction. Therefore, and because the startle sessions were not designed to explore habituation, the habituation effects were not evaluated f urther. The startle responses of each animal were summed to give one integrated startle response value for each animal and trial type; these were then used in subsequent analyses. The PREPUL SE AL ON E responses were barely measurable and were omitted from f urther analyses.
Pearson product-moment correlation analysis was performed for each genotype group of drug-naive mice to assess the relationship between the startle response magnitude and PPI. The extent of PPI is usually determined as PPI%, according to the formula [100 Ϫ (mean startle amplitude on PREPUL SE ϩ PUL SE Ϫ trials/mean startle amplitude on PUL SE AL ON E trials) ϫ 100]. Because both the startle amplitudes and the PPI% appeared to be altered by the mutations, and because startle magnitude after PUL SE AL ON E is used in the denominator of PPI%, the relationship between the startle reflex and PPI phenomena was examined f urther. The correlation coefficients were calculated for relationships between absolute startle magnitudes after PUL SE AL ON E and PREPUL SE ϩ PUL SE as well as the absolute PPI (ϭ startle magnitude after PUL SE AL ON E Ϫ startle magnitude after PRE-PUL SE ϩ PUL SE). It should also be stressed that the wild-type control mice representing two different background strains had different startle and PPI levels, as expected (L ogue et al., 1997; Paylor and Crawley, 1997) , and that statistical comparisons were made only between the appropriate mutant and wild-type groups. Before the calculation of linear correlation, the data were plotted on a scatter plot to detect possible nonlinear associations; such associations were not found.
Results from isolation -aggression tests and the startle experiments with drug-naive mice were analyzed with Mann -Whitney U tests between mutant and respective wild-type groups, because startle responses and attack latencies were not normally distributed. However, nonparametric statistical methods for multivariate analysis are not available, and results from drug challenges were thus analyzed with parametric statistics using two-or three-way ANOVA. Three-way ANOVA for repeated measurements revealed that in the second experiment, in which multiple prepulse intensities (3, 6, 9, and 15 dB above background) were used, the PPI was dependent on prepulse intensity, as expected (prepulse intensity ϫ PPI% interaction: p Ͻ 0.0001). However, the different prepulse intensities had no effect on the differences between drug doses or genotypes. Therefore, for clarity, only the PPI results after the 9 dB above background prepulses are shown from these experiments.
RESULTS
Startle responses and PPI in drug-naive mice with altered ␣ 2C -adrenoceptor expression
The average startle amplitudes to PUL SE AL ON E stimuli were greater in ␣ 2C -KO mice compared with ␣ 2C -KO-wt mice (Z ϭ 2.1; p ϭ 0.034), whereas ␣ 2C -OE and ␣ 2C -OE-wt mice had similar startle responses (Fig. 1 A, B) . The prepulses inhibited startle responses less in ␣ 2C -KO mice (Z ϭ 2.6; p ϭ 0.011) and more in ␣ 2C -OE mice (Z ϭ 3.0; p ϭ 0.0028), when compared with ␣ 2C -KO-wt and ␣ 2C -OE-wt mice (Fig. 1C,D) .
Effects of subtype nonselective ␣ 2 -adrenoceptor drugs on startle responses and PPI The specific, subtype nonselective ␣ 2 -antagonist Ati increased the startle response in ␣ 2C -OE and ␣ 2C -OE-wt mice compared with respective vehicle-treated mice (mean change: ϩ22%; two-way ANOVA, dose effect: F (1,67) ϭ 5.0; p ϭ 0.028) (Fig. 2 A) . A low dose of the subtype nonselective ␣ 2 -AR agonist Dex also slightly increased the startle response (ϩ24%; F (1,65) ϭ 6.0; p ϭ 0.017), but a larger, slightly sedative dose of Dex clearly decreased the startle response (Ϫ55%; p Ͻ 0.0001) (Fig. 2 A) . Although the drug effects seemed to be slightly different between the genotypes (Fig.  2 A) , two-way ANOVA did not indicate any significant drug ϫ genotype interactions between ␣ 2C -OE and ␣ 2C -OE-wt mice in the startle responses.
Ati abolished the PPI differences between ␣ 2C -OE and ␣ 2C -OE-wt mice that were observed after vehicle injections and in the drug-naive mice (two-way ANOVA, drug ϫ genotype interaction: F (1,67) ϭ 5.5; p ϭ 0.022) (Fig. 2 B) . Also the small dose of Dex (3 g/kg) abolished the PPI difference between the genotypes, enhancing only the PPI of ␣ 2C -OE-wt mice (dose ϫ genotype: F (1,65) ϭ 4.8; p ϭ 0.033). The larger dose of Dex (10 g/kg) increased PPI in both ␣ 2C -OE and ␣ 2C -OE-wt mice (dose effect: F (1,67) ϭ 16; p ϭ 0.0001; dose ϫ genotype: F (1,67) ϭ 0.57; p ϭ 0.44).
Effects of D-amphetamine and phencyclidine on startle responses and PPI
The results from D-Amph and PCP challenges are presented in Figures 3A-D and 4 A-D , respectively. A significant genotype difference was observed between ␣ 2C -KO and ␣ 2C -KO-wt mice in their average startle responses to pulse alone stimuli after D-Amph (F (1,90) ϭ 9.0; p ϭ 0.0034); the responses differed between genotypes, especially at the 0.5 mg/kg dose (Fig. 3A ) (Tukey's post hoc test: p ϭ 0.018). Startle amplitudes were similar in ␣ 2C -OE and ␣ 2C -OE-wt mice and were not influenced by D-Amph. There was also a significant difference in startle amplitudes between ␣ 2C -KO and ␣ 2C -KO-wt mice after PCP (F (1,90) ϭ 8.3; p ϭ 0.0049) (Fig. 4 A) . PCP clearly increased the startle amplitudes of ␣ 2C -OE-wt mice, but had a smaller effect in ␣ 2C -OE mice (Fig. 4 B) difference in startle responses between ␣ 2C -OE mice and their wild-type controls was opposite to the difference observed between ␣ 2C -KO mice and their controls. PPI was not statistically significantly different between ␣ 2C -KO and ␣ 2C -KO-wt mice after D-Amph in overall ANOVA. PCP potently disrupted PPI in both ␣ 2C -KO and ␣ 2C -KO-wt mice (dose effect: F (3,90) ϭ 4.9; p ϭ 0.0035) without significant differences in responses between the genotypes (Fig. 4C) .
In ␣ 2C -OE and ␣ 2C -OE-wt mice, D-Amph did not have any detectable effect on the PPI. The difference in PPI between genotypes was perhaps even more prominent than earlier without drug (Figs. 1 D, 3D ) (overall genotype difference: F (1,83) ϭ 29; p Ͻ 0.0001). PC P diminished the PPI also in ␣ 2C -OE-mice, but not in ␣ 2C -OE-wt mice (dose effect: F (3,77) ϭ 3.1; p ϭ 0.034; dose ϫ genotype interaction: F (3,77) ϭ 2.8; p ϭ 0.048) (Fig. 4 D) .
The effect of isolation on startle and prepulse inhibition
After isolation, the average startle responses to PUL SE ALONE stimuli were larger in ␣ 2C -KO mice than in ␣ 2C -KO-wt mice, as observed earlier in group-housed mice (Figs. 1 A, 5A) . The startle responses of isolated ␣ 2C -OE mice were slightly attenuated compared with isolated ␣ 2C -OE-wt mice (Fig. 5B ) (Z ϭ 2.0; p ϭ 0.049) in contrast to group-housed ␣ 2C -OE and ␣ 2C -OE-wt mice, in which no differences between genotype groups were seen in their PUL SE AL ON E responses (Fig. 1 B) .
The differences in PPI, previously observed between genotypes, were now evident only as trends without significance. This probably resulted from lack of statistical power, because the differences in the average responses were similar to those observed earlier in group-housed mice; the group sizes of the studied isolated mice were considerably smaller (n ϭ 14 -18) than those of the group-housed mice (n ϭ 40 -49). Somewhat surprisingly, compared with group-housed mice, PPI was increased in both ␣ 2C -OE and ␣ 2C -OE-wt mice after isolation (51-56% vs 23-38%, respectively; two-way ANOVA, effect of isolation: F (1,117) ϭ 32; p Ͻ 0.0001) (Figs. 1 D, 5D ). In addition, startle responses to PUL SE AL ON E stimuli were decreased by isolation (effect of isolation: F (1,117) ϭ 6.0; p ϭ 0.016).
Association of startle amplitude and prepulse inhibition
Linear regression analysis of the results from group-housed drugnaive mice revealed substantial negative correlation between individual mean startle responses to PUL SE AL ON E stimuli and PPI% values in the genotype groups of ␣ 2C -KO-wt (r ϭ Ϫ0.45; p ϭ 0.0014) and ␣ 2C -OE mice (r ϭ Ϫ0.54; p ϭ 0.0002), but these variables were independent of each other in the groups of ␣ 2C -KO (r ϭ Ϫ0.078; p ϭ 0.82) and ␣ 2C -OE-wt mice (r ϭ ϩ 0.028; p ϭ 0.61) (Fig. 6, Table 1 ). The relationship between absolute startle magnitudes after PUL SE AL ON E and PREPULSE and PULSE trials was highly dependent (r ϭ 0.82 in ␣ 2C -OE-wt mice and r Ͼ 0.93 in other genotype groups; p Ͻ 0.001), and a weaker but substantial positive correlation was observed also between the PULSE AL ON E and absolute PPI responses (r ϭ 0.46 -0.62; p Ͻ 0.01) ( Table 1) .
Isolation-induced aggression tests
The onset of fighting was clearly dependent on the expression of ␣ 2C -ARs. ␣ 2C -AR overexpression was associated with increased latency to attack (Z ϭ 2.7; p ϭ 0.0078), and the lack of ␣ 2C -AR expression was associated with reduced latency to attack (Z ϭ 2.7; p ϭ 0.0070), when compared with the respective wild-type control mice (Fig. 7) . All mice attacked the BAL B/c target mice within the first 4.5 min, except one ␣ 2C -OE mouse that did not attack at all (the latency was scored as 600 sec). In two cases, the BALB/c mice also attacked, but otherwise they performed only defensive behavior. The number of attacks during the 10 min observation period, however, showed no statistically significant differences between the genotype pairs (Table 2) .
DISCUSSION
The lack of ␣ 2C -AR expression was associated with increased startle reactivity, reduced PPI, and reduced attack latency. The overexpression of ␣ 2C -AR resulted in opposite changes. These Figure 5 . A-D, Prepulse inhibition (PPI) of the startle reflex in drugnaive mice with altered ␣ 2C -AR expression after 7-8 weeks of isolation (n ϭ 14 -18). Compared with group-housed mice ( Fig. 1 A-D Table 1 . Correlations between individual means of startle magnitudes after PULSE alone and PREPULSE (PP) ؉ PULSE stimuli, relative prepulse inhibition (PPI%), and the absolute prepulse inhibition (absolute PPI ‫؍‬ startle amplitude after PULSE alone minus startle amplitude after PP ؉ PULSE stimuli) Correlation coefficients are shown separately for each genotype group of drug-naive mice [ϭ mice lacking the ␣ 2C -AR (␣ 2C -KO), mice overexpressing the ␣ 2C -AR (␣ 2C -OE), and respective wild-type (wt) controls; n ϭ 40 -49/group]. Pearson product-moment analysis: *p Ͻ0.05; **p Ͻ0.01; ***p Ͻ0.001.
contrasting findings strongly support the significance of the observed differences and their causal relationship to altered ␣ 2C -AR expression, because the two pairs of mutant and wild-type mouse strains are independent of each other. In addition, the ␣ 2 -AR agonist Dex and the antagonist Ati were capable of abolishing the PPI difference between ␣ 2C -OE and ␣ 2C -OE-wt mice. Taken together, these findings suggest that activation of ␣ 2C -ARs reduces the hyper-reactivity and impulsivity of mice, which are common features of the studied paradigms.
Current opinion generally assumes that the startle reflex amplitude and its prepulse inhibition, determined usually as PPI%, are independent variables and that startle amplitude and PPI are not necessarily correlated. In the present study, negative correlations were observed between the startle amplitude and the PPI%, i.e., the greater the reactivity to the PUL SE AL ON E stimuli, the smaller the relative inhibition in the startle magnitude by prepulse. These correlations were present only in those genotype groups with marked PPI efficacy (mean PPI% Ͼ35; ␣ 2C -KO-wt and ␣ 2C -OE), but not when PPI was weak (mean PPI% Ͻ24; ␣ 2C -KO and ␣ 2C -OE-wt). This suggests that the extent of PPI may be responsible for these now observed negative correlations, but it simultaneously supports the notion that ␣ 2C -ARs are involved in the modulation of both the startle reflex and its PPI. Also two recent studies with mice have explored differences in the startle and PPI of multiple inbred strains. In one study, which compared 12 different mouse strains, the average startle magnitude and PPI% were not correlated over the strains (Paylor and Crawley, 1997) , whereas in another study in 20 strains a positive correlation (r ϭ 0.57; p Ͻ 0.01) was observed between the average startle amplitude evoked by a weak auditory stimulus (90 dB) and PPI% (Logue et al., 1997) . However, in these studies the correlations were analyzed using group means of the markedly different mouse strains, whereas in the present study the analyzed values were individual means of mice having similar strain backgrounds within a group, which obviously can explain, at least partly, the discrepancies. The results support the possibility that calculation of PPI% is the best simple way to control the relationships between startle magnitude and its PPI. Nevertheless, the association between startle and PPI is currently not clear, and the now observed negative correlations may raise the question of whether more sophisticated mathematical methods should be developed to explore the startle plasticity.
The interpretation of the results from D-Amph tests is limited by the failure of D-Amph to produce clear effects on startle responses or PPI% in any of the studied mouse strains. This was probably because of the mild dosage (Dulawa and Geyer, 1996) . However, the startle amplitude difference between ␣ 2C -KO and ␣ 2C -KO-wt genotypes was pronounced after D-Amph. After PCP stimulations, the startle responses of ␣ 2C -KO mice were again larger than those of their controls, whereas ␣ 2C -OE mice had smaller startle amplitudes than ␣ 2C -OE-wt mice. This suggests that the inhibitory contribution of ␣ 2C -ARs on the startle response may increase in stimulated conditions. In contrast to the D-Amph doses that were used, the PCP doses were sufficient to reduce PPI as expected. In conclusion, the stimulation experiments with D-Amph and PCP were in line with the results from drug-naive mice, but they provided only limited additional information on the mechanisms involved in the modulation of the startle response and PPI by ␣ 2C -ARs.
These results and current knowledge do not allow us to identify the probable multiple neural structures that are involved in the inhibitory role of ␣ 2C -ARs in CNS reactivity. The startle reflex itself may be partly spinally modulated by ␣ 2 -ARs , but otherwise the mechanisms are obviously supraspinal, involving the cortico-striato-pallido-pontine circuitry (Geyer et al., 1990) . According to in situ mRNA and immunohistochemical studies, ␣ 2A -ARs are expressed widely throughout the CNS and in peripheral tissues, ␣ 2B -ARs are present mainly in the periphery, and ␣ 2C -ARs have a distinct expression pattern in the brain (Nicholas et al., 1993; Scheinin et al., 1994; Nicholas et al., 1996; Rosin et al., 1996; Talley et al., 1996; Wang et al., 1996) . Compared with ␣ 2A -ARs, the expression of ␣ 2C -ARs in the CNS is generally less abundant and their distribution is more concentrated into distinct structures, such as some hippocampal and cortical regions and the nucleus accumbens and other striatal nuclei, which are important structures in the pathophysiology of impaired PPI. Nevertheless, it is unclear in which types of neurons each of the ␣ 2 -ARs are expressed. It is generally agreed that ␣ 2 -ARs couple to adenylyl cyclases and ion channel regulation through inhibitory G i /0 -type proteins, which also supports the observed inhibitory characteristics of ␣ 2C -ARs in this study.
The results from previous aggression studies with ␣ 2 -ARsubtype-nonselective drugs in rodents are inconsistent and diffi- cult to interpret. One possible explanation for this is the complexity of adrenoceptor interactions when both pre-and postsynaptic ␣ 2 -ARs are affected with drugs lacking subtype selectivity. In addition, it has been postulated that the drug injection per se may mask the possible aggression-heightening effects of small doses of ␣ 2 -AR antagonists in mice (Haller et al., 1996) ; the genetic approach used in this study circumvents this problem. Targeted disruption of the mouse gene encoding neuronal nitric oxide synthase has recently been reported to enhance aggression without preceding isolation (Nelson et al., 1995) . Of other targeted gene disruptions, those leading to lack of 5-HT 1B receptors and the neuropeptide precursor pre-proenkephalin also enhance aggression, manifesting especially as shortened attack latency after isolation (Sadou et al., 1994; König et al., 1996) . The mice with altered ␣ 2C -AR expression, when normally housed in groups, do not differ markedly from their wild-type cage mates in their aggressiveness. Therefore, N E and ␣ 2C -ARs may not have a specific role in the development of enhanced aggression. Rather, the isolation possibly induces a complex neural process in which ␣ 2C -ARs may subserve an inhibitory f unction when a strange stimulus is introduced (Bell and Hepper, 1987) . On the other hand, 5-HT is known to be an important modulator of aggression; therefore, ␣ 2C -AR-dependent modulation of brain 5-HT systems may also explain these findings. Opposite to the now observed relationships between startle amplitude, PPI, and aggression is the finding that mice with targeted disruption of the 5-HT 1B receptor gene that were more aggressive than their wildtype controls (Sadou et al., 1994) had reduced startle amplitude and increased PPI (Dulawa et al., 1997) . Another contradictory finding in this study was that the isolation increased or did not have an effect on PPI, whereas isolation has clearly disrupted PPI in rats (Geyer et al., 1993; Varty and Higgins, 1995) . It is possible that mice and rats have significant differences in their startle and PPI responsiveness. This possibility is supported by a recent report in which the 5-HT 1A agonist 8-OH-DPAT increased PPI in mice (Dulawa et al., 1997) , whereas in previous studies with rats 8-OH-DPAT disrupted PPI (Rigdon and Weatherspoon, 1992; Sipes and Geyer, 1995) . Previous results from startle experiments in humans are in good agreement with the current results, because the classical subtype nonselective ␣ 2 -AR agonist clonidine has been shown to reduce and the ␣ 2 -AR antagonist idazoxan to facilitate the acoustic startle response (Morgan et al., 1993; Kumari et al., 1996) , but the role of ␣ 2 -ARs in PPI is not clear. Interestingly, clonidine has been suggested to be beneficial in the treatment of various neuropsychiatric disorders, although its clinical usef ulness has not been proven (Ahmed and Takeshita, 1996) . In recent studies performed with gene-targeted mice with dysf unctional ␣ 2A -ARs, the sedative and hypotensive effects of nonselective ␣ 2 -AR agonists were blocked by the ␣ 2A -AR disruption Hunter et al., 1997; Lakhlani et al., 1997) , whereas the hypotensive or sedative responses to ␣ 2 -AR agonists are not significantly altered in ␣ 2C -KO mice (Link et al., 1995; Sallinen et al., 1997) . Thus, it is possible that the therapeutic benefit and clinical acceptance of clonidine in neuropsychiatric disorders might have been restricted by the adverse effects of hypotension and sedation, which seem to be mediated solely by ␣ 2A -ARs. Furthermore, some of the atypical neuroleptics, such as clozapine and risperidone, have been reported to have moderate affinity to ␣ 2 -ARs in vivo and especially to the human ␣ 2C -AR subtype in vitro (Schotte et al., 1996) . In light of the present results, it would be interesting to compare the f unctional effects of various antipsychotics at different ␣ 2 -AR subtypes, and to screen for polymorphisms of the ␣ 2C -AR gene among various psychiatric patients.
In summary, ␣ 2C -ARs modulate the startle reflex and its prepulse inhibition and aggressive behavior in mice. Because symptomatology related to the now studied paradigms is present in several patient categories, it is possible that yet to be developed subtype-selective ␣ 2C -AR drugs might have therapeutic value in the treatment of schizophrenia and also other neuropsychiatric disorders with pathological hyper-reactivity and affective disturbances, such as schizophrenia, attention deficit hyperactivity disorder, post-traumatic stress disorder, and drug withdrawal symptoms.
